Navigation Links
Vitacon Receives FDA 510(k) Clearance and Creates US Presence
Date:11/16/2012

MINNEAPOLIS, Nov. 16, 2012 /PRNewswire/ -- Vitacon AS, located in Trondheim, Norway, announces major milestones as it continues to expand its global reach. Vitacon has received FDA clearance on its VitaScan LT USB bladder scanner. Vitacon also announces signing a marketing and distribution partnership with SALUS, the Minneapolis-based life science advisory firm.

(Photo: http://photos.prnewswire.com/prnh/20121116/CG14322)

Non-invasive bladder scanning has become a valuable diagnostic tool. Measuring bladder volume helps avoid indwelling urethral catheters, a major cause of infection. CAUTI (catheter-associated urinary tract infection) treatment is no longer reimbursed if it happens while a patient is hospitalized, thus a major incentive exists to prevent it. 

VitaScan LT enables real-time bladder volume measurement in hospitals, clinics, and home health. It connects via USB to laptop and tablets, providing nearly limitless storage and data transmission capabilities. VitaScan software utilizes intelligent targeting algorithms enabling personnel with limited training to obtain accurate measurements in seconds.

SALUS was selected by Vitacon to implement a US marketing and distribution strategy. "The selection of SALUS is essential to our growth," says Kristin Waro, CEO of Vitacon. "We found their approach unique as they not only created a thorough strategy, but also have the expertise and distribution connections to execute the plan."

SALUS will be responsible for pre-sales support, logistics, and customer service for a nationwide network of distributors. Spencer Lien, SALUS CEO, says, "Vitacon hit our market perfectly, responding to the need for speed, mobility, and cost-effectiveness. Our research indicates a void in the marketplace and we are confident the respective channels to healthcare providers will be equally impressed."

About Vitacon: 

Vitacon AS was founded in 1985 in Trondheim, Norway. Vitacon develops products to treat incontinence and diagnose bladder dysfunction. Vitacon products are well-known throughout Europe.  The company has moved into diagnostic ultrasound and recently launched the VitaScan series of ultrasound scanners offering flexible and cost-effective solutions in bladder volume measurements.

About SALUS:

Salus Consilium, LLC was founded in 2008 by veteran medtech entrepreneur, Spencer Lien. The firm specializes in advising new medical technology ventures and established companies on growth strategies and technology management. Headquartered in Minnesota's "Medical Alley," SALUS offers a variety of services including business development, regulatory and reimbursement strategies, commercialization plans, intellectual property management, and technology transfer.

Website: www.vitacon.com

Website: www.TeamSalus.com


'/>"/>
SOURCE Salus Consilium, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hiker without Human Heart Receives Heart Transplant 607 Miles Later
2. Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900
3. Beyond Lucid Technologies Receives Funding From Dalmore Investments
4. MedeAnalytics Receives Leadership Award from Ventana Research
5. STD Med Inc. Receives ANVISA Registration for Class III Medical Devices in Brazil
6. OptiNose Receives Grant to Fund Nose-to-Brain Research in Autism Spectrum Disorders
7. Hyland Softwares R4 ACERT Perinatal Reporting System Receives Meaningful Use Certification
8. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
9. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
10. American Board of Radiology Foundation receives grant from Varian Medical Systems for national brachytherapy registry
11. Sihuans First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... , ... Journal of Oral Implantology – Tooth loss is not ... health, including complications with speech, eating, and overcompensation of mouth due to the deficiency. ... As the number of tooth replacements increase, it is imperative to design an implant ...
(Date:4/26/2017)... ... 2017 , ... Elisabete Miranda, president and CEO of ... magazine as one of its 2017 Enterprising Women of the Year, a prestigious ... that they have fast-growth businesses, mentor or actively support other women and girls ...
(Date:4/26/2017)... NJ (PRWEB) , ... April 26, 2017 , ... RawTrition ... an easy way to get nutrients from SUPERFOODS! , RawTrition is taking ... at the cellular level because the body recognizes its raw form (unlike the synthetically ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, ... to announce that it has received 510(k) clearance from the U.S. Food & ... the MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition Duchenne, ... Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on ... clinical trial in Duchenne announced today. , Coalition Duchenne funded studies carried ...
Breaking Medicine News(10 mins):